South Africa weighs local HIV jab production costs
South Africa evaluates local HIV jab production costs for lenacapavir (LEN), weighing speed and affordability to boost access to this new six-monthly prevention
South Africa evaluates local HIV jab production costs for lenacapavir (LEN), weighing speed and affordability to boost access to this new six-monthly prevention
Floods and pollution in Nairobi and Johannesburg force displacement, sickness, and long-term harm for residents like Faith Atieno,…
South Africa evaluates local HIV jab production costs for lenacapavir (LEN), weighing speed and affordability to boost access…
Cancer patients may face logistical challenges during treatment, about one of life's toughest experiences.
HIV funding cuts force the closure of 1,714 clinics worldwide. Learn how shrinking donations impact global health efforts…
Ovarian cancer patient Gertrude Spatafora shares how faith and family support helped her navigate treatment after a shocking…